Lexicon Pharmaceuticals (LXRX) had the highest return in September 2019 by a US stock in the Biotechnology Industry, returning 123%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Lexicon Pharmaceuticals (LXRX) | September 2019 | 122.96% |
Ovid Therapeutics (OVID) | September 2019 | 83.05% |
Clene (CLNNW) | September 2019 | 73.47% |
Edesa Biotech (EDSA) | September 2019 | 60.98% |
Kazia Therapeutics Ltd ADR (KZIA) | September 2019 | 56.9% |
Organogenesis (ORGO) | September 2019 | 56.43% |
VistaGen Therapeutics (VTGN) | September 2019 | 55.07% |
Bicycle Therapeutics (BCYC) | September 2019 | 52.48% |
Eterna Therapeutics (ERNA) | September 2019 | 51.35% |
Capricor Therapeutics (CAPR) | September 2019 | 48% |
Mesoblast (MESO) | September 2019 | 42.89% |
Portage Biotech (PRTG) | September 2019 | 42.86% |
Ideaya Biosciences (IDYA) | September 2019 | 37.4% |
Replimune (REPL) | September 2019 | 35.21% |
Summit Therapeutics (SMMT) | September 2019 | 33.58% |
ACADIA Pharmaceuticals (ACAD) | September 2019 | 31.73% |
Oragenics (OGEN) | September 2019 | 31.71% |
Kodiak Sciences (KOD) | September 2019 | 31.56% |
Solid Biosciences LLC (SLDB) | September 2019 | 30.89% |
Avita Medical (RCEL) | September 2019 | 30.41% |
Kiora Pharmaceuticals (KPRX) | September 2019 | 30.2% |
Cyclerion Therapeutics (CYCN) | September 2019 | 28.12% |
ESSA Pharma (EPIX) | September 2019 | 26.22% |
Quince Therapeutics (QNCX) | September 2019 | 25.97% |
XBiotech (XBIT) | September 2019 | 24.67% |
